Study record managers: refer to the Data Element Definitions if submitting registration or results information.
|1||NCT02849990||Active, not recruiting||A Phase II Neoadjuvant Study of Apalutamide, Abiraterone Acetate, Prednisone, Degarelix and Indomethacin in Men With Localized Prostate Cancer Pre-prostatectomy||
||Other / Industry / NIH||
||22||Male||18 Years and older (Adult, Older Adult)||NCT02849990||9628
|March 9, 2017||December 10, 2018||December 10, 2020||July 29, 2016||February 22, 2019||